SASTESCINE

This brand name is authorized in Nigeria.

Active ingredients

The drug SASTESCINE contains one active pharmaceutical ingredient (API):

1	Butylscopolamine UNII 0GH9JX37C8 - BUTYLSCOPOLAMINE BROMIDE
	Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs.
	Read more about Butylscopolamine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100546	Injection	SASTESCINE INJECTION INJ 10 mg 1ml x 10Ampoules	42 NF-PP-224534 SASTESCINE INJECTION HYSOCINE BUTYLBROMIDE INJECTION Each ml contains: Hyoscine BUTYLBROMIDE BP 10mg water for Injection BP Q .s Drugs Imported Products 1mlx10Ampoules POM 1 8/8/2021 SASTEK MEGA PHARMA & CHEMICAL COMPANY LTD, 10A ABAYOMI STREET, OFF OLARENWAJU STREET, OREGUN, IKEJA, LAGOS 8036857486 sastekmegapharmachem@gmail.com MAKCUR LABORATORIES LIMITED, 46/5-5-7, VILLAGE-ZAK, TAL-DEHGAM, DIST: GANDHINAGAR- 30 GUJARAT, INDIA, India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A03BB01	Butylscopolamine	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03B BELLADONNA AND DERIVATIVES, PLAIN → A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
Discover more medicines within A03BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100546